Results 81 to 90 of about 2,233,111 (188)
Antiplatelet drug resistance in patients with coronary heart disease
Кардиоваскулярная терапия и профилактика, 2012 Coronary angioplasty is an important component of coronary heart disease (CHD) management. There is a substantial evidence of the need for dual antiaggregant therapy (clopidogrel and aspirin) in this clinical group, both before and after the intervention.
V. A. Sulimov, E. V. Moroz
doaj +1 more source
Advanced Science, Volume 13, Issue 49, 3 September 2026.Epsilon‐near‐zero (ENZ) silicon carbide enables a selective far‐infrared emitter spectrally aligned with the human skin window around 10 µm for wavelength‐matched thermal therapy. In 25 within‐subject trials (50 hands) monitored by laser speckle contrast imaging, SiC increases blood perfusion by 30.2% versus a broadband graphite emitter while ...
Wen‐Teng Yao +3 more
wiley +1 more source
, 2023 Mazzaccaro D, Giannetta M, Ranucci M, Righini P, Di Dedda U, Baryshnikova E, Milani V, Nano G. Clopidogrel Resistance and Ticagrelor Replacement in Dual Antiplatelet Therapy for Carotid Artery Stenting. Ann Vasc Surg.
Daniela Mazzaccaro +7 more
core +1 more source
Aspirin and Clopidogrel Resistance: Consideration and Management
Journal of Interventional Cardiology, 2006 The efficacy with aspirin and clopidogrel treatment has been demonstrated in various clinical trials. Laboratory evaluation of platelet response in recent studies revealed that a distinctive response variability and nonresponsiveness/resistance in selected patients were associated with these antiplatelet agents.
Paul A, Gurbel, Udaya S, Tantry
openaire +2 more sources
Advanced Science, Volume 13, Issue 53, 24 September 2026.Bioinspired passive flow routing mitigates thrombosis in cardiovascular devices by redirecting a small fraction of forward flow into stagnation‐prone regions. Inspired by avian alula and aircraft slat mechanisms, strategically placed routing channels restore washout around mechanical heart valves, reducing low‐shear exposure by four orders of magnitude
Yevgeniy Kreinin +8 more
wiley +1 more source
Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration
BMEMat, Volume 4, Issue 3, September 2026.The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang +13 more
wiley +1 more source
Progress in Synthesis and Pharmacology of Telmisartan
Chemistry &Biodiversity, Volume 23, Issue 9, September 2026.Telmisartan is a benzimidazole derivative and a well‐known drug to treat hypertension. This review provides synthesis and understanding of telmisartan as an antihypertensive drug through two mechanisms of actions: RAAS inhibitor and PPARγ receptor. Effective repurposing of this drug for various diseases like chronic kidney illness, diabetes, fatty ...
Megha, Richa Srivastava, Ram Singh
wiley +1 more source
Cochrane Evidence Synthesis and Methods, Volume 4, Issue 5, September 2026.ABSTRACT Introduction Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem‐solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), that is, defining a clinical question, locating relevant literature, preliminary screening, study ...
Ana M. Barragán +5 more
wiley +1 more source
Prevalence of clopidogrel resistance evaluated by the VASP method [PDF]
, 2010 BACKGROUND: Despite oral antiplatelet treatment a certain number of patients suffer adverse events while on therapy. Whether patients demonstrating low platelet inhibition in vitro are at increased risk for adverse events is unknown.
Dahl, Karine Haug
core
A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI
Indian Heart Journal, 2015 Background: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival.
P.C. Rath +9 more
doaj +1 more source